BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
  NCT04038502 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.